Glipizide (Compound)

Synonyms:glipizide, 29094-61-9, Glucotrol, Glydiazinamide, Melizide, Glibenese, Glucozide, Glupizide, Sucrazide, Dipazide, Glupitel, Mindiab, Minidiab, Minodiab, Napizide, Ozidia, Glucotrol XL, Glibetin, Glucolip, Aldiab, Digrin, Glican, Glidiab, Glipid, Minidab, Glyde, Gluco-Rite, Glipizida, Glipizidum, Glipizidum [INN-Latin], K 4024, Glipizida [INN-Spanish], N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide, CP 28720, K-4024, CP-28720, TK 1320, CP 28,720, N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide, Glipizide slow release, CP-28,720, 1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea, Glide, NSC-759120, CHEMBL1073, X7WDT95N5C, MLS000069386, Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-, CHEBI:5384, CP 28720;K 4024, DTXSID0040676, N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide, N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea, N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide, NCGC00015462-07, SMR000058455, CAS-29094-61-9, 1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea, Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-, 29094-66-4, DTXCID8020676, 1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea, N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea, Glucotrol (TN), Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-, Glipizide (USP/INN), SR-01000000010, EINECS 249-427-6, MFCD00072159, UNII-X7WDT95N5C, BRN 0903495, Glipizide, solid, N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-5-methylpyrazine-2-carboxamide, Glipizide [USAN:USP:INN:BAN], glipizide/glucotrol, Glipizide,(S), Prestwick_242, KS-1068, Metaglip (Salt/Mix), Glipizide (Glucotrol), GLIPIZIDE [INN], GLIPIZIDE [JAN], GLIPIZIDE [MI], Lopac-G-117, GLIPIZIDE [USAN], Opera_ID_1908, Prestwick0_000131, Prestwick1_000131, Prestwick2_000131, Prestwick3_000131, GLIPIZIDE [VANDF], G-117, GLIPIZIDE [MART.], 1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea, GLIPIZIDE [USP-RS], GLIPIZIDE [WHO-DD], CBiol_001788, Lopac0_000621, SCHEMBL17094, BSPBio_000202, BSPBio_001349, KBioGR_000069, KBioSS_000069, MLS001148176, BIDD:GT0476, SPBio_002141, BPBio1_000224, GTPL6821, GLIPIZIDE [ORANGE BOOK], GLIPIZIDE [EP MONOGRAPH], KBio2_000069, KBio2_002637, KBio2_005205, KBio3_000137, KBio3_000138, GLIPIZIDE [USP MONOGRAPH], Bio1_000074, Bio1_000563, Bio1_001052, Bio2_000069, Bio2_000549, HMS1361D11, HMS1568K04, HMS1791D11, HMS1989D11, HMS2089C21, HMS2093J09, HMS2095K04, HMS2233N11, HMS3259K12, HMS3261N04, HMS3369L12, HMS3402D11, HMS3655G04, HMS3712K04, Pharmakon1600-01505433, METAGLIP COMPONENT GLIPIZIDE, BCP09195, HY-B0254, Tox21_110156, Tox21_301834, Tox21_500621, BBL028143, BDBM50012956, NSC759120, NSC813218, s1715, STK631952, AKOS005564405, GLIPIZIDE COMPONENT OF METAGLIP, N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide, Tox21_110156_1, CCG-204710, DB01067, LP00621, NC00564, NSC 759120, NSC-813218, SDCCGSBI-0050603.P003, IDI1_033819, N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide, Glipizide 100 microg/mL in Acetonitrile, NCGC00015462-01, NCGC00015462-02, NCGC00015462-03, NCGC00015462-04, NCGC00015462-05, NCGC00015462-06, NCGC00015462-08, NCGC00015462-09, NCGC00015462-10, NCGC00015462-11, NCGC00015462-12, NCGC00015462-14, NCGC00015462-23, NCGC00016802-01, NCGC00023748-03, NCGC00023748-04, NCGC00023748-05, NCGC00023748-06, NCGC00023748-07, NCGC00255522-01, NCGC00261306-01, AC-15789, SBI-0050603.P002, EU-0100621, FT-0626714, FT-0659737, G0369, SW196549-3, D00335, Q3108899, SR-01000000010-2, SR-01000000010-5, W-107005, BRD-K12219985-001-04-8, BRD-K12219985-001-15-4, Z1575081877, Glipizide, European Pharmacopoeia (EP) Reference Standard, Glipizide, United States Pharmacopeia (USP) Reference Standard, Glipizide, Pharmaceutical Secondary Standard; Certified Reference Material, 1-cyclohexyl-3-(4-(2-(2-methylpyrazine-5-carboxamido)ethyl)phenylsulfonyl)urea, 1-Cyclohexyl-3-{{p=[2-[5-methylpyrazine-carboxamido)-ethyl]phenyl}sulphonyl}urea, N-(4-(.beta.-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea, 172964-66-8, 2-Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-, N-(2-[4-(([(Cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-5-methyl-2-pyrazinecarboxamide
Pubchem:PUBCHEM:3478
Id:e62d2bc9-f67c-5edd-8803-11560d464dc2
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Glipizide's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Glipizide.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Glipizide.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.